RhumbLine Advisers’s Zymeworks ZYME Stock Holding History

RhumbLine Advisers’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.89M	Sell	75,399 -99	-0.1%	-$2.34K	﹤0.01%	1887
2025 Q4	$1.99M	Sell	75,498 -10,404	-12%	-$227K	﹤0.01%	1880
2025 Q3	$1.47M	Sell	85,902 -181	-0.2%	-$2.59K	﹤0.01%	2060
2025 Q2	$1.08M	Buy	86,083 +3,345	+4%	+$39.8K	﹤0.01%	2204
2025 Q1	$985K	Sell	82,738 -21,138	-20%	-$288K	﹤0.01%	2177
2024 Q4	$1.52M	Buy	103,876 +15,920	+18%	+$223K	﹤0.01%	2029
2024 Q3	$1.1M	Buy	87,956 +1,044	+1%	+$11.4K	﹤0.01%	2221
2024 Q2	$740K	Buy	86,912 +7,210	+9%	+$64.2K	﹤0.01%	2412
2024 Q1	$838K	Buy	79,702 +2,105	+3%	+$23.4K	﹤0.01%	2345
2023 Q4	$806K	Buy	77,597 +5,490	+8%	+$43.8K	﹤0.01%	2381
2023 Q3	$457K	Buy	72,107 +2,093	+3%	+$15.5K	﹤0.01%	2663
2023 Q2	$605K	Buy	+70,014	New	+$627K	﹤0.01%	2572

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RhumbLine Advisers's ZYME Position: Q1 2026 in Review

RhumbLine Advisers reduced its Zymeworks (ZYME) stake by 0.13% in Q1 2026, selling an estimated $2.34K and leaving 75,399 shares worth $1.89M. The position accounts for ﹤0.01% of the portfolio, ranked #1887.

RhumbLine Advisers first reported a position in ZYME in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.99M in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

RhumbLine Advisers held 75,399 shares of Zymeworks worth $1.89M as of Q1 2026.
RhumbLine Advisers sold 99 Zymeworks shares in Q1 2026, an estimated $2.34K.
Zymeworks made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #1887 holding.
RhumbLine Advisers first reported a position in Zymeworks in Q2 2023 and has held it in 12 quarters since.
RhumbLine Advisers's Zymeworks position peaked at $1.99M in Q4 2025.
211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.